Holen Sie sich die Stockscreener-App
161.25
1.26%
-2.06
Vorhandelsmarkt:
161.80
0.55
+0.34%
Schlusskurs vom Vortag:
$163.31
Offen:
$160.95
24-Stunden-Volumen:
528.96K
Relative Volume:
0.62
Marktkapitalisierung:
$7.94B
Einnahmen:
$4.06B
Nettoeinkommen (Verlust:
$413.08M
KGV:
20.13
EPS:
8.01
Netto-Cashflow:
$560.48M
1W Leistung:
-1.50%
1M Leistung:
-3.39%
6M Leistung:
-2.46%
1J Leistung:
-18.46%
1-Tages-Spanne:
$158.69
$162.44
1-Wochen-Bereich:
$158.69
$165.22
52-Wochen-Spanne:
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
Firmenname
Charles River Laboratories International Inc
Sektor
Branche
Telefon
781-222-6000
Adresse
251 BALLARDVALE ST, WILMINGTON, MA
Vergleichen Sie CRL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
161.25 | 8.04B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-23 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2025-05-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-05-08 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-03-04 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-03-03 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2025-01-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-18 | Herabstufung | CLSA | Hold → Underperform |
| 2024-11-07 | Hochstufung | CLSA | Underperform → Hold |
| 2024-10-23 | Eingeleitet | CLSA | Underperform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Sell |
| 2024-10-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-01 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-08-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Herabstufung | Argus | Buy → Hold |
| 2024-06-07 | Eingeleitet | Mizuho | Neutral |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-09-13 | Eingeleitet | TD Cowen | Market Perform |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-02-23 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-01-12 | Herabstufung | Jefferies | Buy → Hold |
| 2022-09-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-04 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | Eingeleitet | Guggenheim | Neutral |
| 2022-04-25 | Herabstufung | Jefferies | Buy → Hold |
| 2022-04-07 | Eingeleitet | Stephens | Overweight |
| 2022-02-17 | Bestätigt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-02-17 | Bestätigt | Deutsche Bank | Buy |
| 2022-02-17 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-17 | Bestätigt | UBS | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2020-07-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-05-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-03-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-02-18 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | Hochstufung | Goldman | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-18 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | Eingeleitet | SVB Leerink | Outperform |
| 2019-04-30 | Fortgesetzt | Evercore ISI | Outperform |
| 2018-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-08-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Sentiment analysis tools applied to Charles River Laboratories International Inc.Portfolio Risk Report & Intraday High Probability Alerts - Newser
Using AI based signals to follow Charles River Laboratories International Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Leading vs lagging indicators on Charles River Laboratories International Inc. performanceWeekly Investment Report & Technical Confirmation Alerts - Newser
Measuring Charles River Laboratories International Inc.’s beta against major indicesEntry Point & Daily Oversold Bounce Ideas - Newser
Institutional scanner results for Charles River Laboratories International Inc.Recession Risk & Weekly Chart Analysis and Guides - Newser
Will Charles River Laboratories International Inc. stock go up soonEarnings Beat & Risk Controlled Stock Alerts - Newser
Chart overlay techniques for tracking Charles River Laboratories International Inc.July 2025 Final Week & Risk Managed Investment Signals - Newser
Published on: 2025-09-03 01:36:19 - Newser
Building trade automation scripts for Charles River Laboratories International Inc.Quarterly Market Review & Consistent Profit Trading Strategies - Newser
Price momentum metrics for Charles River Laboratories International Inc. explainedJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
Regression analysis insights on Charles River Laboratories International Inc. performanceChart Signals & Reliable Price Action Trade Plans - Newser
How high can Charles River Laboratories International Inc. stock goProduct Launch & Accurate Buy Signal Alerts - Newser
Developing predictive dashboards with Charles River Laboratories International Inc. data2025 Market Sentiment & Weekly High Return Opportunities - Newser
Is Charles River Laboratories International Inc. likely to announce a buybackPortfolio Gains Report & Smart Investment Allocation Insights - خودرو بانک
Applying Wyckoff theory to Charles River Laboratories International Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Will Charles River Laboratories International Inc. benefit from geopolitical trendsWeekly Earnings Recap & Reliable Momentum Entry Alerts - خودرو بانک
Does Charles River Laboratories International Inc. stock have upside surprise potentialWeekly Profit Summary & Weekly Return Optimization Plans - خودرو بانک
Is Charles River Laboratories International Inc. forming a breakout patternJuly 2025 Volume & Community Consensus Trade Signals - خودرو بانک
Can a trend reversal in Charles River Laboratories International Inc. lead to recoveryMarket Movement Recap & Fast Entry Momentum Alerts - Newser
How sentiment analysis helps forecast Charles River Laboratories International Inc. - Newser
Is Charles River Laboratories International Inc. stock bottoming outQuarterly Market Review & Community Consensus Trade Signals - Newser
Advanced analytics toolkit walkthrough for Charles River Laboratories International Inc.Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
Tools to assess Charles River Laboratories International Inc.’s risk profileMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Real time scanner hits for Charles River Laboratories International Inc. explainedDividend Hike & Safe Capital Growth Tips - Newser
Using data filters to optimize entry into Charles River Laboratories International Inc.CEO Change & Stock Market Timing Techniques - Newser
Published on: 2025-09-02 00:42:17 - Newser
Charles River Laboratories International Inc. stock volume spike explainedTrade Entry Summary & Real-Time Buy Zone Alerts - Newser
What earnings revisions data tells us about BigBear.ai Holdings Inc. Equity WarrantTrade Entry Summary & High Conviction Buy Zone Picks - Newser
How to use a screener to detect Charles River Laboratories International Inc. breakoutsJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
How to track smart money flows in Charles River Laboratories International Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
What is Charles River Laboratories International Inc. s 5 year growth outlookRate Hike & Daily Market Momentum Tracking - خودرو بانک
Technical analysis overview for Charles River Laboratories International Inc. stock - Newser
Risk vs reward if holding onto Charles River Laboratories International Inc.Price Action & Reliable Entry Point Trade Alerts - Newser
Is Charles River Laboratories International Inc. meeting your algorithmic filter criteria2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - Newser
Charles River Stock May Benefit From Joining EASYGEN Consortium - sharewise.com
Recap Report: Is Charles River Laboratories International Inc. likely to announce a buybackJuly 2025 Recap & Accurate Technical Buy Alerts - خودرو بانک
Short interest data insights for Banco Santander S.A. Depositary ReceiptMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
Stock Analysis | Charles River Laboratories International OutlookMixed Signals Amid Earnings Optimism - AInvest
Published on: 2025-08-31 21:05:47 - Newser
Visualizing Charles River Laboratories International Inc. stock with heatmapsQuarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
Charles River Laboratories International Inc. stock trendline breakdownMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Charles River Laboratories International Inc. Reversal Rally May Surprise Bears2025 Fundamental Recap & Fast Exit/Entry Strategy Plans - beatles.ru
Analyzing Charles River Laboratories International Inc. with risk reward ratio charts2025 Retail Activity & Real-Time Volume Analysis - Newser
Has Charles River Laboratories International Inc. found a price floorPortfolio Return Report & Entry and Exit Point Strategies - Newser
What high frequency data says about Charles River Laboratories International Inc.Quarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Combining price and volume data for Charles River Laboratories International Inc.July 2025 Action & Target Return Focused Picks - Newser
Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):